Vanguard Fiduciary Trust
LEXX icon

Vanguard Fiduciary Trust’s Lexaria Bioscience LEXX Stock Holding History

Vanguard Fiduciary Trust’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.7K Hold
6,278
– – ﹤0.01% 3853
2026
Q1 		$73.4K Buy
+6,278
New +$68.4K ﹤0.01% 3765

Other funds holding LEXX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust's LEXX Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its Lexaria Bioscience (LEXX) position steady in Q2 2026 at 6,278 shares worth $52.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3853.

Vanguard Fiduciary Trust first reported a position in LEXX in Q1 2026 and has held it in 2 quarters since. The position peaked at $73.4K in Q1 2026. 27 funds tracked by Wall St. Rank hold LEXX as of Q2 2026.

  • Vanguard Fiduciary Trust held 6,278 shares of Lexaria Bioscience worth $52.7K as of Q2 2026.
  • Vanguard Fiduciary Trust left its Lexaria Bioscience share count unchanged in Q2 2026.
  • Lexaria Bioscience made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3853 holding.
  • Vanguard Fiduciary Trust first reported a position in Lexaria Bioscience in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Lexaria Bioscience position peaked at $73.4K in Q1 2026.
  • 27 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.